Interventions of Interest
- ensifentrine (Verona Pharma)
Chronic obstructive pulmonary disease (COPD) is a group of lung diseases characterized by
progressive and persistent airflow obstruction in the lungs. COPD affects approximately 15.7
million people in the United States, with higher rates among non-Hispanic White individuals, Native American individuals, women, and adults older than 65.
For questions please contact Liis Shea, Senior Program Director, lshea@icer.org.
View the Key Stakeholder List.
Public Comments
Closed